Dimetindene maleate
This medicine should always be taken exactly as described in this patient leaflet or as directed by a doctor or pharmacist.
Fenistil contains dimetindene maleate, which belongs to a group of antihistamine medicines. It inhibits the action of histamine - a substance responsible for allergic reactions. It relieves itching and irritation caused by skin rash, reduces swelling, and also relieves symptoms of allergic rhinitis, such as runny nose (cold), sneezing, nasal itching, and eye itching and tearing.
After oral administration, the effect of the medicine starts within 30-60 minutes and lasts for 8 to 12 hours.
Fenistil is used to treat symptoms of allergic diseases:
Before starting to take Fenistil, the patient should discuss it with their doctor, pharmacist, or nurse.
The patient should consult their doctor before taking this medicine if they have:
Elderly patients should contact their doctor before taking this medicine, as they are more susceptible to the side effects of this medicine, such as excitement and fatigue.
The medicine should not be taken by elderly patients with disorientation.
Antihistamines can cause excitement in small children.
The use of Fenistil in infants from 1 month to 1 year of age and in children under 6 years of age should be done on the advice of a doctor.
The recommended dose should not be exceeded.
The medicine should be kept out of sight and reach of children.
The patient should tell their doctor about all medicines they are currently taking or have recently taken, including those available without a prescription.
Without a doctor's recommendation, Fenistil should not be taken in case of taking any of the following medicines:
Like other antihistamines, Fenistil may enhance the effect of alcohol.
If the patient is pregnant or breastfeeding, thinks they may be pregnant, or plans to have a child, they should consult their doctor or pharmacist before taking this medicine.
Fenistil should not be taken during pregnancy, unless the benefits to the mother outweigh the potential risk to the fetus. The medicine should only be used under medical supervision.
Fenistil should not be taken by breastfeeding women.
As with other antihistamines, Fenistil may impair psychophysical performance in some patients. Therefore, patients taking Fenistil in the form of oral drops should be cautious when driving vehicles or performing other activities that require concentration (e.g., operating machines).
The medicine contains 2 mg of benzoesic acid per dose (40 drops), which corresponds to 1 mg/ml.
Benzoesic acid may increase the risk of jaundice (yellowing of the skin and whites of the eyes) in newborns (up to 4 weeks of age).
The medicine contains 200 mg of propylene glycol per dose (40 drops), which corresponds to 100 mg/ml.
Before administering the medicine to a child under 4 weeks of age, the patient should consult their doctor or pharmacist, especially if the child is taking other medicines containing propylene glycol or alcohol.
The medicine contains less than 1 mmol (23 mg) of sodium per dose (40 drops), which means the medicine is considered "sodium-free".
This medicine should always be taken exactly as described in this patient leaflet or as directed by a doctor, pharmacist, or nurse.
In case of doubt, the patient should consult their doctor, pharmacist, or nurse.
The recommended dose should not be exceeded.
The use of Fenistil in infants from 1 month to 1 year of age and in children under 6 years of age should be done on the advice of a doctor. The medicine should not be taken by children under 1 month of age.
The medicine should not be taken for more than 7 days.
If there is no improvement after 7 days or the patient feels worse, they should contact their doctor.
Adults and children over 12 years of age:
The daily dose is 3-6 mg of dimetindene, given in 3 divided doses.
It is recommended to take 20-40 drops 3 times a day.
In patients with a tendency to drowsiness, 40 drops should be taken before bedtime and 20 drops in the morning, during breakfast.
Children under 12 years of age:
The recommended daily dose is 0.1 mg/kg body weight/day, given in 3 divided doses, e.g.,
6 drops 3 times a day in the case of an 8-month-old infant weighing 9 kg.
8 drops 3 times a day in the case of a 2-year-old child weighing 12 kg.
The maximum daily dose should not be exceeded, which is:
1 month - 1 year
1.5 mg
30 drops
20 drops = 1 ml = 1 mg of dimetindene
Fenistil should not be exposed to high temperatures. If the infant is bottle-fed, the medicine should be added to the bottle with warm food immediately before feeding. If the infant is spoon-fed, the drops can be given undiluted, on a small teaspoon.
Elderly patients should contact their doctor before taking this medicine.
In case of overdose, the patient should immediately consult their doctor or pharmacist.
Symptoms of overdose are: drowsiness (mainly in adults), central nervous system stimulation (mainly in children and elderly patients), including excitement, coordination disorders, hallucinations, tremors, convulsions, and urinary retention and fever. There may be a decrease in blood pressure, coma, and cardiovascular and respiratory collapse.
In case of a missed dose, the patient should take it as soon as possible, unless there are less than 2 hours left before the next dose. In this case, the patient should take the medicine at the usual time. The patient should not take a double dose to make up for the missed dose.
In case of any further doubts about taking this medicine, the patient should consult their doctor or pharmacist.
Like all medicines, Fenistil can cause side effects, although not everybody gets them.
The patient should STOPtaking the medicine and immediately consult their doctor if they experience any of the following symptoms, which may be signs of an allergic reaction:
These symptoms occur very rarely(may occur less often than in 1 in 10,000 patients).
Other side effects that may occur are usually mild and temporary. The most common side effects occur especially at the beginning of treatment.
Very common(may occur in more than 1 in 10 people taking the medicine): fatigue.
Common(occur in less than 1 in 10 people taking the medicine): drowsiness, nervousness.
Rare(may occur in less than 1 in 1,000 people taking the medicine): excitement, headache, dizziness, gastrointestinal disorders, nausea, dry mouth, dry throat.
If any of the side effects get worse or if the patient experiences any side effects not listed in this leaflet, they should inform their doctor or pharmacist.
If the patient experiences any side effects, including those not listed in this leaflet, they should tell their doctor, pharmacist, or nurse.
Side effects can be reported directly to the Department of Post-Marketing Surveillance of Medicinal Products, Medical Devices, and Biocidal Products: Al. Jerozolimskie 181C, 02-222 Warsaw, tel. +48 22 49 21 301, fax: +48 22 49 21 309.
Side effects can also be reported to the marketing authorization holder.
Reporting side effects will help to gather more information on the safety of the medicine.
Fenistil should be stored at a temperature below 25°C.
The bottle should be kept in the packaging.
The medicine should be kept out of sight and reach of children.
The medicine should not be taken after the expiry date stated on the carton and bottle.
The expiry date refers to the last day of the month stated.
Medicines should not be disposed of via wastewater or household waste.
The patient should ask their pharmacist how to dispose of medicines that are no longer needed.
This will help protect the environment.
Fenistil is a solution, clear, colorless to slightly yellowish-brown, in an orange glass bottle with a polyethylene dropper and a polypropylene cap, or a polypropylene child-resistant cap, placed in a carton box.
Available packaging:20 ml and 100 ml.
Haleon Poland Sp. z o.o.
ul. Rzymowskiego 53
02-697 Warsaw
tel. 800 702 849
Haleon Germany GmbH
Barthstrasse 4
80339 Munich
Germany
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.